Abstract:
A biocontainment vessel includes a vessel structure including a structural composition and an enhancement composition associated with the structural composition. The enhancement composition includes a co-polymer. The co-polymer is a poly(glycerol sebacate) or a poly(glycerol sebacate urethane). The enhancement composition may also include an augmentation agent associated with the co-polymer. The enhancement composition is located with respect to the structural composition such that the enhancement composition benefits biological cells contained in the biocontainment vessel. A composition includes a co-polymer and an augmentation agent contained by the co-polymer. A method of containing biological cells includes placing the biological cells in an augmented biocontainment vessel and storing them in the augmented biocontainment vessel under predetermined conditions. An augmented substrate includes a substrate and an enhancement composition coating a surface of the substrate.
Abstract:
Plaque pour la biologie cellulaire, comprenant un support (1) biocompatible, un empilement sur le support (1) de films souples biocompatibles, l'empilement comprenant un puits traversant l'empilement jusqu'au support, dans laquelle les films de l'empilement sont engagés, entre eux et avec le support, dans une liaison mécanique permettant le pelage.
Abstract:
A microfluidic device for processing cells for the intracellular delivery of molecules or other cargo includes a plurality of microchannels disposed in a substrate or chip and fluidically coupled to an inlet configured to receive a solution containing the cells and the molecules or other cargo to be delivered intracellularly to the cells. Each of the plurality of microchannels has one or more constriction regions therein, wherein the constriction regions comprise an omniphobic, superhydrophilic, or superhydrophobic surface. In some embodiments, multiple microfluidic devices operating in parallel are used to process large numbers of cells. The device and method has particularly applicability to delivering gene-editing molecules intracellularly to cells.
Abstract:
The invention relates to an amphiphilic block copolymer comprising a first block consisting of a polymeric hydrophilic domain, wherein the polymeric hydrophilic domain consists of a polyglycerol; an optional second block consisting of a hydrophobic domain and a first linker domain, wherein the second block is covalently bound to the first block via the first linker domain, wherein the hydrophobic domain is chosen from the group consisting of aromatic residues having 3 to 20 carbon atoms, aliphatic residues having 3 to 20 carbon atoms, oligo(dimethylsiloxane), and poly(dimethylsiloxane); an optional third block consisting of a catechol domain and a second linker domain, wherein the third block is covalently bound to the first block via the second linker domain, wherein the catechol domain comprises at least one catechol residue; and a forth block consisting of a crosslinking domain and a third linker domain, wherein the forth block is covalently bound to the first block via the third linker domain, wherein the crosslinking domain comprises a reactive residue enabling a crosslinking between individual molecules of the amphiphilic block copolymer, wherein the reactive residue is at least one residue chosen from the group consisting of amines, thiols, allyls, vinyls, azides, alkynes, carboxyls, anhydrides, aldehydes, and benzophenone.
Abstract:
A method of culturing autogenous cells as well as a method of treating a mammalian patient is described. The cells are cultured on a substrate material having a surface treated with a fatty acid ester so as to have a strong hydrophobic surface and autogenous plasma obtained from a blood sample of the patient is used as a growth medium in order to culture the cells. The substrate material is also used as a transfer dressing for transferring the cultured cells to the patient and as a wound cover dressing. The invention also describes a kit as well as a system for culturing autogenous cells using the culture method.
Abstract:
Two-dimensional materials, particularly graphene-based materials, having a plurality of apertures therein can be formed into enclosures for various substances and a fibrous layer can be provided on an outside and/or on an inside of the enclosure. The enclosures can be exposed to an environment, such as a biological environment (in vivo or in vitro), where the fibrous layer can promote vascular ingrowth. One or more substances within the enclosure can be released into the environment, one or more selected substances from the environment can enter the enclosure, one or more selected substances from the environment can be prevented from entering the enclosure, one or more selected substances can be retained within the enclosure, or combinations thereof. The enclosure can, for example, allow a sense-response paradigm to be realized. The enclosure can, for example, provide immunoisolation for materials, such as living cells, retained therein.
Abstract:
The presently disclosed subject matter provides an approach to address the needs for microscale control in shaping the spacial geometry and microarchitecture of 3D collagen hydrogels. For example, the disclosed subject matter provides for compositions, methods, and systems employing N-sulfosuccinimidyl-6-(4'-azido-2'- nitro-phenylamino)hexanoate ("sulfo-SANPAH"), to prevent detachment of the hydrogel from the anchoring substrate due to cell-mediated contraction.
Abstract:
The presently disclosed subject matter provides a biomimetic lung disease model, and methods of its production and use. In one exemplary embodiment, the biomimetic lung disease model can include a first and second microchannel with a membrane coated with airway epithelial cells disposed between the microchannels and at least one device coupled to the biomimetic model that delivers an agent to at least one microchannel. In certain embodiments, the agent is cigarette smoke.
Abstract:
The present invention relates to a cell culture device comprising a mesh comprising or made of a biocompatible polymer; and a top grid comprising or made of a biocompatible polymer, laying over the said mesh; wherein the mesh is a monolayer of cross-linked nanofibers and has a specific surface ranging from 20% to 40%; the top grid comprises a single grid and an array of openings separated by partitions having a width; each opening of the top grid has the same geometric configuration; and the top grid comprises a border surrounding the openings, the said border having a width at least two times greater than the width of the said partitions. The present invention also relates to a method for manufacturing said cell culture device, a method of cell growth or differentiation and a cell culture system.
Abstract:
Bei einem Großbehälter (1), mit einem Boden und einer geschlossen umlaufenden Wand (3), wobei die Wand (3) eine Vielzahl einzelner, miteinander verbundener Platten (6) aufweist, schlägt die Erfindung vor, dass die Platten (6) an ihrer ins Behälterinnere gerichteten Innenseite jeweils mit einer Folie (7) versehen sind, wobei die aneinander grenzenden, benachbarten Folien (7) durch Dichtnähte flüssigkeitsdicht miteinander verbunden sind.